Evidence-based prescribing of statins: a developing world perspective.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 16478294.
- Also identified by PMC identifier 1370919.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
Although statins reduce the incidence of cardiovascular disease, they are expensive. How should trial evidence on statins be applied to a resource-poor setting?
Medical subject headings
- Cardiovascular Diseases
- Developing Countries
- Hydroxymethylglutaryl-CoA Reductase Inhibitors